strong buy otc hsta pk creates 5 th vital sign tri state capital proudly presents heartstat technology inc otc hsta pk heartstat new revolutionary technology great multiple market potential strong patent position proprietary systems involved decade rd heartstat plans extraordinary financial performance moving healthcare well 21 st century believe heartstat poised tremendouse growth market product increasing 2 1 billion revenues 200 million projected representing 10 market share management believes exit opportunities exist within three years yield roi well excess 35 annually otc hsta heartstat technology inc closing price 0 70 cents 52 week hi 1 10 52 week lo 0 40 www heartstat com heartstat monitor slips patient arm measures 1 blood pressure bp heart rate continuous basis 2 much blood heart pumps e blood flow hs continuous blood pressure monitor already fda approved blood flow monitor uses similar non invasive technology easily pass fda clearance remember using device simple sticking band aid patient arm future heartstat heartstat revolutionist routine icu er care ultimately every place patients assessed including e g local doctors offices ambulances provide complex essential data simpler manner routine bp cuffs tell us blood pressure readings distant future allow optimizations millions patients e g heart drugs internet heartstat represents true revolution health care rapidly become standard care need heartstat one difficult things medicine decide sick simple way even super trained specialists critical care doctors anesthetists find difficult recognize patient going tube traditional eyeballing patient plus classic four vital signs blood oxygen levels cut tell little late prevention always better cure heartstat allows us treat patients become catastrophically ill key blood flow blood flow within patient body currently methods achieve costly complicated perform potentially lethal complications done highly trained experts estimated five percent patients need monitoring costs inherent risks desperately needed simple non invasive device measures blood flow holy grail modern medicine heartstat overview heartstat technology inc heartstat developed bringing market first practical system monitoring blood flow perfusion oxygen transport important heart dynamics noninvasive continuous uses simple comfortable disposable sensor addresses key issues hospital critical care blood pressure bp pulse oximeter pox devices means preventive monitoring managing cardiovascular disease however commonly misleading slow reflect abnormality often late present cardiac output measurement restricted critical procedures 5 patients risks costs blood flow perfusion early specific indications managing vital patient risks yet monitoring practical highlights company significant product market advantages life science based cardiovascular measurement unrestricted use fda easy grandfathered noninvasive product clearances first practical patient friendly system market tested first price competitive cnbp 3 000 vs 6 000 others disposable patient sensor rapid growth contamination avoidance large markets enormous cost savings life saving justifications cost effective dealer selling nil training complexity proprietary sensing formidable barrier competition comprehensive fundamental patents filed worldwide financial company hospital business projections reflect breakeven profits two years following performance three five years marketing revenues 65 200 market share 3 10 marketing costs 25 28 revenues ebit 24 91 net income 22 28 revenues annual discounted return 115 110 based 15 pe ratio liquidity exit opportunities favorable terms capital company pursue marketing relationships hospitals spin partnership opportunities following applications outside market focus internet based cardiovascular disease management drug interaction monitoring physician offices patient homes miniature cuff less device avert heart attacks closed loop adaptive drug delivery control systems diagnostic stress testing biophysic stress heart dynamics disclaimer tri state capital feature stock reports intended stock ideas recommendations please research investing crucial least look current sec filings read latest press releases information contained report extracted current documents filed sec company web site publicly available sources deemed reliable information see disclaimer section link found web site document contains forward looking statements particularly related business plans company within meaning section 27 securities act 1933 sections 21 e securities exchange act 1934 subject safe harbor created sections actual results may differ materially company expectations estimates advertisement softnet technology purpose advertisement like advertising provide coverage awareness company information provided advertisement intended distribution use person entity jurisdiction country distribution use would contrary law regulation would subject us registration requirement within jurisdiction country 1998 2004 tristatecapital com rights reserved tri state capital registered broker dealer financial advisor hold materials presented web site individual reports released public web site e mail means transmission regarded investment advice informative purposes making purchase sale securities featured web site mentioned reports strongly encourage recommend consultation registered securities representative construed solicitation recommendation buy sell securities stock companies select profile involve degree investment risk volatility particularly small caps otc bb stocks investors cautioned may lose portion investment decide make purchase profiled companies past performance profiled stocks indicative future results accuracy completeness information web site within reports reliable sources obtained profile opinions expressed herein expressed date profile posted site subject change without notice investor assume reliance views opinions recommendations contained herein produce profitable results tri state capital may hold positions securities mentioned herein may make purchases sales securities featured web site within reports order full compliance securities act 1933 section 17 b tri state capital disclose disclaimer compensation received efforts researching presenting disseminating information subscriber database featuring report tri state capital web site tri state capital compensated eleven thousand five hundred free trading registered shares third party efforts presenting sttc profile web site distributing database subscribers well services tri state capital may decide purchase sell shares voluntary basis open market profiling period report profile date shares sold information presented web site within reports contain forward looking statements within meaning section 27 securities act 1933 section 21 e securities exchange act 1934 statements express involve discussions respect predictions expectations beliefs plans projections objectives goals assumptions future events performance statements historical fact may forward looking statements forward looking statements based expectations estimates projections time statements made involve number risks uncertainties could cause actual results events differ materially presently anticipated forward looking statements action may identified use words expects anticipates estimates believes statements indicating certain actions may could might occur reader verify claims due diligence investing securities mentioned investing small cap securities speculative carries high degree risk encourage readers invest carefully read investor information available web sites securities exchange commission sec http www sec gov national association securities dealers nasd http www nasd com readers review public filings companies sec edgar page nasd published information invest carefully web site subscription information subscription email 21556 subscribe zinester com subscription url http www zinester com mpb ml _ fs cgi topic 21556 unsubscription email 21556 unsubscribe zinester com unsubscription url http www zinester com mpb unsub cgi 21556